Ionis Pharmaceuticals, Inc. | LinkedIn (original) (raw)

Biotechnology Research

Carlsbad, CA 74,017 followers

Building on our impossible firsts, we can change the course of human health.

About us

For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients.

Industry

Biotechnology Research

Company size

501-1,000 employees

Headquarters

Carlsbad, CA

Type

Public Company

Founded

1989

Specialties

RNA-targeted medicines and RNA-targeted therapeutics

Locations

Employees at Ionis Pharmaceuticals, Inc.

Updates

Curious about our recruiting process, our offices, our employee resource groups, or our one-of-a-kind culture? Ever wonder what it’s like to work on a team that develops and delivers breakthrough therapies that have the potential to change patients’ lives? You’re in luck! Drop your questions in the comment section below by 1/29, and Alison Sitt, our manager of Talent Acquisition, will spill the beans 2/5 on the Ionis Instagram: https://lnkd.in/dD6zDZZv
HCPs: Plasma prekallikrein (PKK), a key effector in the kallikrein-kinin system that acts downstream of activated factor XII and upstream of kallikrein and bradykinin, represents a unique target in hereditary angioedema (#HAE). Learn more about how RNA-targeted medicines offer the potential to regulate disease-causing genes and their variants. https://lnkd.in/d5vswx8V
74,017 followers
1w Edited
Join us Wednesday for a business update presented by our CEO, Brett P. Monia, PhD, highlighting our next chapter as a commercial-stage biotech with multiple independent launches and continued pipeline momentum on the horizon. Learn more: https://lnkd.in/emj4FwyC #JPM2025
One week until the 43rd Annual J.P. Morgan Healthcare Conference. We’re looking forward to gathering in San Francisco to discuss the latest and greatest innovations in healthcare. Our CEO, Brett P. Monia, PhD, will present a business update on Wednesday previewing numerous commercial, regulatory and pipeline milestones for Ionis in 2025. A live webcast of the presentation can be accessed on the Investors & Media section of the Ionis website: https://lnkd.in/ePNUAbCX.#JPM2025
74,017 followers
1mo Edited
2024 has been a pivotal year for Ionis. We couldn’t have achieved all we have without the dedication, passion and hard work of our Ions, as well as the support and collaboration of our partners. Thank you for an amazing year. See you in 2025! https://lnkd.in/dwaMDXr5
Seth Baum M.D., MASPC, FACC, FAHA, FNLA shares what the availability of a new treatment means to the FCS community. Learn more: https://lnkd.in/eg2G4NpH
Familial chylomicronemia syndrome (FCS) has a profound impact on the lives of patients and their families. FCS is a rare, genetic and potentially life-threatening disease that causes debilitating daily symptoms. We're proud of our long-standing partnership with the FCS community and are honored to bring forward a first and only treatment option for adults #livingwithFCS in the U.S. Learn more: https://lnkd.in/eg2G4NpH
The FDA approval of our breakthrough treatment – the first and only medicine in the U.S. for adults with familial chylomicronemia syndrome (FCS), as an adjunct to diet – is an important milestone for this rare disease community. Watch this video from our CEO, Brett P. Monia, PhD, to learn more about the significance of this approval.

Join now to see what you are missing

Join now

Browse jobs

Stock

IONS

January 23, 2025

NASDAQ

20 minutes delay

Open

32.58

Low

32.52

High

34.98

Data from Refinitiv

See more info on Bing

Ionis Pharmaceuticals, Inc. | LinkedIn (original) (raw)

Biotechnology Research

Carlsbad, CA 74,017 followers

Building on our impossible firsts, we can change the course of human health.

About us

Locations

Employees at Ionis Pharmaceuticals, Inc.

Updates

Join now to see what you are missing

Similar pages

Browse jobs

Stock

Funding